Analystreport

Melinta Therapeutics (NASDAQ: MLNT) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating.

MELINTA THERAPEUTICS INC  (MLNT) 
Last melinta therapeutics inc earnings: 11/12 04:39 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.melinta.com/investor-relations